Apollo Hospitals Enterprise Limited (APOLLOHOSP): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Apollo Hospitals Enterprise Limited, explained in plain English.

• ▪Apollo Hospitals Enterprise Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪APOLLOHOSP closed at ₹8,200.00 on 29 October 2026.
• ▪Over the past year the shares are up 4.3%, trading between ₹6,696.50 and ₹9,070.50.
• ▪Reported fundamentals show a net margin of 7.91%, debt to equity of 85.15.
• ▪Our transparent MaxGrade checklist scores it D (38/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 20.82% with a maximum drawdown of -16.2% and a beta of 0.57 against NIFTY 50.
• ▪Recent coverage: Swiggy may rebound to Rs 190, but charts do not signal a trend reversal: LKP’s Vatsal Bhuva
• ▪Recent coverage: JioBlackRock Flexicap down 6.67% in 2026: 19 fresh buys, 18 exits in September reshuffle
• ▪Recent coverage: Fortis Healthcare, Apollo Hospitals, Max, Medanta shares rise: Should investors buy after 30% cancer drug price cap?

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Aster DM Quality Care, Aurobindo Pharma, Biocon

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.